Erratum to: CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes (Journal of Molecular Medicine, (2016), 94, 11, (1255-1265), 10.1007/s00109-016-1433-0);CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes

Journal of Molecular Medicine

Volumn 94, Issue 11, 2016, Pages 1255-1265

  Beli, Eleni ^a   Dominguez, James M ^a,b   Hu, Ping ^a   Thinschmidt, Jeffrey S ^b   Caballero, Sergio ^b   Li Calzi, Sergio ^a   Luo, Defang ^b   Shanmugam, Sumathi ^d   Salazar, Tatiana E ^a,b   Duan, Yaqian ^a   Boulton, Michael E ^a   Mohr, Susanna ^c   Abcouwer, Steven F ^d   Saban, Daniel R ^e   Harrison, Jeffrey K ^b   Grant, Maria B ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CX3CR1; Diabetes; IL 10; Macrophages; Retinopathy

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 10; TUMOR NECROSIS FACTOR; AUTACOID; CX3CR1 PROTEIN, MOUSE; GLYCOSYLATED HEMOGLOBIN; MESSENGER RNA; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOCYTE MACROPHAGE PRECURSOR CELL; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RODENT MODEL; VASCULARIZATION; ANIMAL; BODY WEIGHT; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENE DELETION; GENETICS; HOMEOSTASIS; HYPOTHALAMUS; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY; RETINA;

ANIMALS; APOPTOSIS; BODY WEIGHT; BONE MARROW CELLS; CX3C CHEMOKINE RECEPTOR 1; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; GENE DELETION; GLYCATED HEMOGLOBIN A; HOMEOSTASIS; HYPOTHALAMUS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYELOID CELLS; RETINA; RNA, MESSENGER; STREPTOZOCIN;

EID: 84976285388     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-017-1530-8     Document Type: Erratum

References (46)

1. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R, American Diabetes A (2003) Diabetic retinopathy. Diabetes Care 26(Suppl 1):S99–S102
2. Simo R, Hernandez C (2015) ç. Prog Retin Eye Res 48:160-180. doi:10.1016/j.preteyeres.2015.04.003
3. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52(2):1156–1163
4. Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30(5):343–358
5. Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin AT, Allen DM, Cardona AE (2014) The role of microglia in diabetic retinopathy. J Ophthalmol 2014:705783
6. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45(9):3330–3336
7. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K (2010) Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 53(5):971–979
8. Yang Y, Mao D, Chen X, Zhao L, Tian Q, Liu C, Zhou BL (2012) Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice. Mol Vis 18:1411–1420
9. Kern TS, Tang J, Berkowitz BA (2010) Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16:2121–2131
10. Cherry JD, Olschowka JA, O'Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98
11. Schwartz M, Baruch K (2014) The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J 33(1):7–22
12. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ et al (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91(4):521–530
13. Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30(1):87–97
14. Thomas G, Tacke R, Hedrick CC, Hanna RN (2015) Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vasc Biol 35(6):1306–1316
15. Chakravarthy H, Beli E, Navitskaya S, O'Reilly S, Wang Q, Kady N, Huang C, Grant MB, Busik JV (2016) Imbalances in mobilization and activation of pro-inflammatory and vascular reparative bone marrow-derived cells in diabetic retinopathy. PLoS One 11(1):e0146829
16. Chakravarthy H, Navitskaya S, O'Reilly S, Gallimore J, Mize H, Beli E, Wang Q, Kady N, Huang C, Blanchard GJ, Grant MB, Busik JV (2015) Role of acid sphingomyelinase in shifting the balance between pro-inflammatory and reparative bone marrow cells in diabetic retinopathy. Stem cells. doi:10.1002/stem.2259
17. Hazra S, Jarajapu YP, Stepps V, Caballero S, Thinschmidt JS, Sautina L, Bengtsson N, Licalzi S, Dominguez J, Kern TS et al (2013) Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 56(3):644–653
18. Hu P, Thinschmidt JS, Yan Y, Hazra S, Bhatwadekar A, Caballero S, Salazar T, Miyan JA, Li W, Derbenev A et al (2013) CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol 183(5):1608–1620
19. Yellowlees Douglas J, Bhatwadekar AD, Li Calzi S, Shaw LC, Carnegie D, Caballero S, Li Q, Stitt AW, Raizada MK, Grant MB (2012) Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 31(5):481–494
20. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9(7):917–924
21. Wolf Y, Yona S, Kim KW, Jung S (2013) Microglia, seen from the CX3CR1 angle. Front Cell Neurosci 7:26
22. Paolicelli RC, Bisht K, Tremblay ME (2014) Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci 8:129
23. Zieger M, Ahnelt PK, Uhrin P (2014) CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies. PLoS One 9(9):e106562
24. Liang KJ, Lee JE, Wang YD, Ma W, Fontainhas AM, Fariss RN, Wong WT (2009) Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling. Invest Ophthalmol Vis Sci 50(9):4444–4451
25. Raoul W, Feumi C, Keller N, Lavalette S, Houssier M, Behar-Cohen F, Combadiere C, Sennlaub F (2008) Lipid-bloated subretinal microglial cells are at the origin of drusen appearance in CX3CR1-deficient mice. Ophthalmic Res 40(3-4):115–119
26. Lu P, Li L, Kuno K, Wu Y, Baba T, Li YY, Zhang X, Mukaida N (2008) Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression. J Immunol 180(6):4283–4291
27. Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D et al (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97(7):1925–1928
28. Kasama T, Wakabayashi K, Sato M, Takahashi R, Isozaki T (2010) Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy. Transl Res J Lab Clin Med 155(1):20–26
29. Lauro C, Catalano M, Trettel F, Limatola C (2015) Fractalkine in the nervous system: neuroprotective or neurotoxic molecule? Annals of the New York Academy of Sciences. doi:10.1111/nyas.12805
30. Serra AM, Waddell J, Manivannan A, Xu H, Cotter M, Forrester JV (2012) CD11b + bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation. Am J Pathol 181(2):719–727
31. Rangasamy S, McGuire PG, Franco Nitta C, Monickaraj F, Oruganti SR, Das A (2014) Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS One 9(10):e108508
32. Cardona SM, Mendiola AS, Yang YC, Adkins SL, Torres V, Cardona AE (2015) Disruption of Fractalkine signaling leads to microglial activation and neuronal damage in the diabetic retina. ASN neuro 7 (5). doi:10.1177/1759091415608204
33. Kezic JM, Chen X, Rakoczy EP, McMenamin PG (2013) The effects of age and Cx3cr1 deficiency on retinal microglia in the Ins2(Akita) diabetic mouse. Invest Ophthalmol Vis Sci 54(1):854–863
34. Bhatwadekar A, Glenn JV, Figarola JL, Scott S, Gardiner TA, Rahbar S, Stitt AW (2008) A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol 92(4):545–547
35. O'Koren EG, Mathew R, Saban DR (2016) Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. Sci Rep 6:20636
36. Abcouwer SF, Lin CM, Wolpert EB, Shanmugam S, Schaefer EW, Freeman WM, Barber AJ, Antonetti DA (2010) Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 51(11):5920–5933
37. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20(11):4106–4114
38. Hu SJ, Calippe B, Lavalette S, Roubeix C, Montassar F, Housset M, Levy O, Delarasse C, Paques M, Sahel JA et al (2015) Upregulation of P2RX7 in Cx3cr1-deficient mononuclear phagocytes leads to increased interleukin-1beta secretion and photoreceptor neurodegeneration. J Neurosci Off J Soc Neurosci 35(18):6987–6996
39. Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, Luedde T, Trautwein C, Tacke F (2010) The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52(5):1769–1782
40. Sennlaub F, Auvynet C, Calippe B, Lavalette S, Poupel L, Hu SJ, Dominguez E, Camelo S, Levy O, Guyon E et al (2013) CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med 5(11):1775–1793
41. Raoul W, Keller N, Rodero M, Behar-Cohen F, Sennlaub F, Combadiere C (2008) Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J Neuroimmunol 198(1-2):56–61
42. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, Pezard A, Lavalette S, Houssier M, Jonet L, Picard E et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117(10):2920–2928
43. Chinnery HR, McLenachan S, Humphries T, Kezic JM, Chen X, Ruitenberg MJ, McMenamin PG (2012) Accumulation of murine subretinal macrophages: effects of age, pigmentation and CX3CR1. Neurobiol Aging 33(8):1769–1776
44. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y et al (2007) Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A 104(7):2425–2430
45. Caballero S, Hazra S, Bhatwadekar A, Li Calzi S, Paradiso LJ, Miller LP, Chang LJ, Kern TS, Grant MB (2013) Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury. Invest Ophthalmol Vis Sci 54(4):3000–3009
46. Fadini GP, de Kreutzenberg SV, Boscaro E, Albiero M, Cappellari R, Krankel N, Landmesser U, Toniolo A, Bolego C, Cignarella A et al (2013) An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 56(8):1856–1866